Form 4: Hims & Hers Health Chief Legal Officer Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,345 shares of Class A Common Stock at $14.65 per share under a pre-arranged 10b5-1 trading plan.
Summary
- On September 3, 2024, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., sold 2,345 shares of Class A Common Stock.
- The sale was executed at a price of $14.65 per share.
- Following the transaction, Boughton directly owns 159,796 shares of Hims & Hers Health, Inc.
- The sale was conducted under a Rule 10b5-1 trading plan adopted on September 10, 2023.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a routine stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment towards the company's prospects.
Industry Context
Sales by company insiders are a common occurrence and are often viewed in the context of pre-arranged trading plans to avoid accusations of trading on material non-public information. The market typically assesses the volume and frequency of such sales to gauge potential impact.
Stakeholder Impact
- The sale of shares by a company officer could have a minor impact on shareholder sentiment, depending on the size of the sale and the context of the trading plan.
Key Dates
| Date | Description |
|---|---|
| 09/10/2023 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person |
| 09/03/2024 | Date of the transaction (stock sale) |
| 09/05/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.